Skip to main content
Erschienen in: The Journal of Obstetrics and Gynecology of India 6/2016

14.06.2015 | Original Article

Comparative Study of Mifepristone with Vaginal Misoprostol for First Trimester Termination of Pregnancy at Different Gestational Ages

verfasst von: Seema Rani Meena

Erschienen in: The Journal of Obstetrics and Gynecology of India | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Methods

This study for medical abortion was conducted in the Department of Obstetrics and Gynaecology, Zenana Hospital, SMS Medical College, Jaipur during 2011–2012. In total 280 cases were taken for the study and divided into two groups, among whom there were six defaulters in each group who failed to present for follow-up.

Objectives

The objectives of this study were to (1) compare the success rates of abortion at different gestational ages, (2) study the side effects of the drugs, and (3) study the acceptability in both the groups.

Results

The medical abortion with the given regimen and protocol was observed to be highly successful, and complete abortion was achieved in 98.51 and 97.76 % of the patients in Group-A and Group-B, respectively. Failure rates observed were only 1.49 % in Group-A and 2.24 % in Group-B.

Conclusions

Medical abortion can be safely performed in cases up to 63 days of gestation, but women should be counseled about the increased blood loss and duration of bleeding.
Literatur
1.
Zurück zum Zitat Kurtkoti K. FOGSI focus on medical abortion. 2010; p. 5, 27, 31. Kurtkoti K. FOGSI focus on medical abortion. 2010; p. 5, 27, 31.
3.
Zurück zum Zitat Unsafe Abortion: Global and regional estimates of the incidence of unsafe abortion and associated mortality in 2003. Fifth edition, Word Health Organization Cataloguing—in—Publication Data. p. 1, 4–6. Unsafe Abortion: Global and regional estimates of the incidence of unsafe abortion and associated mortality in 2003. Fifth edition, Word Health Organization Cataloguing—in—Publication Data. p. 1, 4–6.
4.
Zurück zum Zitat Megh M. FOGSI. Comprehensive abortion care and post abortion contraception, FOGSI focus; 2012. p. 15. Megh M. FOGSI. Comprehensive abortion care and post abortion contraception, FOGSI focus; 2012. p. 15.
5.
Zurück zum Zitat Creinin MD, Schwartz JL, Pymar HC, et al. Efficacy of Mifepristone followed on the same day by Misoprostol for early termination of pregnancy: report of a randomised trial. BJOG. 2001;108:469–73.PubMed Creinin MD, Schwartz JL, Pymar HC, et al. Efficacy of Mifepristone followed on the same day by Misoprostol for early termination of pregnancy: report of a randomised trial. BJOG. 2001;108:469–73.PubMed
6.
Zurück zum Zitat Ashok PW, Penney GC, Flett GMM, et al. An effective regimen for early medical abortion : a report of 2000 consecutive cases. Hum Reprod. 1998;13(10):2962–5.CrossRefPubMed Ashok PW, Penney GC, Flett GMM, et al. An effective regimen for early medical abortion : a report of 2000 consecutive cases. Hum Reprod. 1998;13(10):2962–5.CrossRefPubMed
7.
Zurück zum Zitat Agarwal S, Salhan S. Department of obstetric & gynaecology, VMMC and Safdarganj Hospital, New Delhi, India. Septic abortion—current scenario in a tertiary care hospital. J Obstet Gynecol. 2008;58(2):147–51. Agarwal S, Salhan S. Department of obstetric & gynaecology, VMMC and Safdarganj Hospital, New Delhi, India. Septic abortion—current scenario in a tertiary care hospital. J Obstet Gynecol. 2008;58(2):147–51.
8.
Zurück zum Zitat Deshpande S, Yelikar K, Deshmukh A, et al. Comparative study of medical abortion by Mifepristone with vaginal Misoprostol in women <49 days versus 50–63 days of amenorrhoea. J Obstet Gynecol. 2010;60(5):403–7. Deshpande S, Yelikar K, Deshmukh A, et al. Comparative study of medical abortion by Mifepristone with vaginal Misoprostol in women <49 days versus 50–63 days of amenorrhoea. J Obstet Gynecol. 2010;60(5):403–7.
9.
Zurück zum Zitat Kopp Kallner H, Fiala C, Stephansson O, et al. Home self-administration of vaginal Misoprostol for medical abortion at 50–63 days compared with gestation of below 50 days. Hum Reprod. 2010;25(5):1153–7.CrossRefPubMed Kopp Kallner H, Fiala C, Stephansson O, et al. Home self-administration of vaginal Misoprostol for medical abortion at 50–63 days compared with gestation of below 50 days. Hum Reprod. 2010;25(5):1153–7.CrossRefPubMed
Metadaten
Titel
Comparative Study of Mifepristone with Vaginal Misoprostol for First Trimester Termination of Pregnancy at Different Gestational Ages
verfasst von
Seema Rani Meena
Publikationsdatum
14.06.2015
Verlag
Springer India
Erschienen in
The Journal of Obstetrics and Gynecology of India / Ausgabe 6/2016
Print ISSN: 0971-9202
Elektronische ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-015-0705-x

Weitere Artikel der Ausgabe 6/2016

The Journal of Obstetrics and Gynecology of India 6/2016 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.